GetTopicDetailResponse(id=a1c455e67f8, topicName=抗血管內(nèi)皮生長因子, introduction=抗血管內(nèi)皮生長因子, content=null, image=null, comments=4, allHits=1248, url=https://h5.medsci.cn/topic?id=55767, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=60377, tagList=[TagDto(tagId=60377, tagName=抗血管內(nèi)皮生長因子)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2204041, encodeId=70c92204041a7, content=<a href='/topic/show?id=001e66e77e1' target=_blank style='color:#2F92EE;'>#激光療法#</a> <a href='/topic/show?id=a1c455e67f8' target=_blank style='color:#2F92EE;'>#抗血管內(nèi)皮生長因子#</a> <a href='/topic/show?id=e90b11434603' target=_blank style='color:#2F92EE;'>#新生兒視網(wǎng)膜病變（ROP）#</a>, objectTitle=JAMA子刊：血管內(nèi)皮生長因子（anti-VEGF）藥物aflibercept治療新生兒視網(wǎng)膜病變（ROP）的安全及有效性, objectType=article, longId=825286, objectId=461082528612, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240510/1715336271269_5579292.jpg, objectUrl=/article/show_article.do?id=461082528612, replyNumber=0, likeNumber=79, createdTime=2024-05-11, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=461082528612, moduleTitle=JAMA子刊：血管內(nèi)皮生長因子（anti-VEGF）藥物aflibercept治療新生兒視網(wǎng)膜病變（ROP）的安全及有效性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=461082528612)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2083004, encodeId=9f6720830043f, content=<a href='/topic/show?id=a1c455e67f8' target=_blank style='color:#2F92EE;'>#抗血管內(nèi)皮生長因子#</a>, objectTitle=婦科腫瘤抗血管內(nèi)皮生長因子單克隆抗體臨床應(yīng)用指南, objectType=article, longId=188079, objectId=dfe61880e9cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfe61880e9cb, replyNumber=0, likeNumber=72, createdTime=2020-06-30, rootId=0, userName=ms1692810954239974, userId=0e3a2500177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfe61880e9cb, moduleTitle=婦科腫瘤抗血管內(nèi)皮生長因子單克隆抗體臨床應(yīng)用指南, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=dfe61880e9cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083005, encodeId=2b2220830050f, content=<a href='/topic/show?id=a1c455e67f8' target=_blank style='color:#2F92EE;'>#抗血管內(nèi)皮生長因子#</a>, objectTitle=諾華的抗血管內(nèi)皮生長因子（VEGF）單抗Beovu獲歐盟批準(zhǔn)，用于治療年齡相關(guān)的濕性黃斑變性, objectType=article, longId=188479, objectId=2f351884e941, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f351884e941, replyNumber=0, likeNumber=81, createdTime=2020-09-20, rootId=0, userName=ms1692810954239974, userId=0e3a2500177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f351884e941, moduleTitle=諾華的抗血管內(nèi)皮生長因子（VEGF）單抗Beovu獲歐盟批準(zhǔn)，用于治療年齡相關(guān)的濕性黃斑變性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2f351884e941)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083002, encodeId=6ade2083002dc, content=<a href='/topic/show?id=a1c455e67f8' target=_blank style='color:#2F92EE;'>#抗血管內(nèi)皮生長因子#</a>, objectTitle=Ophthalmologica：視網(wǎng)膜中心靜脈阻塞導(dǎo)致黃斑水腫的抗血管內(nèi)皮生長因子治療方案比較研究！, objectType=article, longId=115307, objectId=dabb11530e33, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dabb11530e33, replyNumber=0, likeNumber=88, createdTime=2018-04-04, rootId=0, userName=ms1692810954239974, userId=0e3a2500177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dabb11530e33, moduleTitle=Ophthalmologica：視網(wǎng)膜中心靜脈阻塞導(dǎo)致黃斑水腫的抗血管內(nèi)皮生長因子治療方案比較研究！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=dabb11530e33)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083003, encodeId=93162083003b6, content=<a href='/topic/show?id=a1c455e67f8' target=_blank style='color:#2F92EE;'>#抗血管內(nèi)皮生長因子#</a>, objectTitle=2018 臨床實踐指南：玻璃體內(nèi)注射抗血管內(nèi)皮生長因子藥物治療眼部血管疾病, objectType=article, longId=137396, objectId=16d913e3966a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16d913e3966a, replyNumber=0, likeNumber=71, createdTime=2018-10-01, rootId=0, userName=ms1692810954239974, userId=0e3a2500177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16d913e3966a, moduleTitle=2018 臨床實踐指南：玻璃體內(nèi)注射抗血管內(nèi)皮生長因子藥物治療眼部血管疾病, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=16d913e3966a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
